General Information
Revision date
2021-09-15
Product name
FLUTICASONE FUROATE/ VILANTEROL DRY POWDER INHALER
Product Synonyms
RELVAR ELLIPTA * BREO ELLIPTA * REVINTY ELLIPTA * REVINTY ELLIPTA 184/22 MCG
1.2.2. Uses advised against
No other uses are advised
Emergency telephone
+1-612-221-3999, Ext 221
Icons in SDS
Company Information
company name
GlaxoSmithKline
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360, H373, H411
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
H373
May cause damage to organs through prolonged or repeated exposure
H411
Toxic to aquatic life with long lasting effects
Section 2
Physical hazards
Not classified.
Health hazards
Reproductive toxicity Category 1B Specific target organ toxicity following Category 2 (Adrenal, Bone, eye, Immune repeated exposure system)
Environmental hazards
Hazardous to the aquatic environment, Category 2
Signal word
Danger
Hazard statements
H360 May damage fertility or the unborn child. H373 May cause damage to organs through prolonged or repeated exposure. H411 Toxic to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/attention. P391 Collect spillage.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
1 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 100 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. National/local information Not available
